From heart in motion to precise treatment

Cardiac ultrasound recorded through the CardioKit probe, looping over one heartbeat, with the tracked target moving in and out of the planned gating window drawn over it.

LIVE ECG Cardio-respiratory Beam on Beam on

Two rhythms, one decision.

01 / The problem

The heart moves.

With every beat and every breath, the target shifts. Without motion management, margins must grow to cover that movement.

Axial CT of the chest at heart level, with a small target drawn on the left ventricular wall and a much larger amber contour around it covering the target's motion. — **Without gating.** The contour covers everywhere the target goes. Everything inside it gets the dose.

The same CT slice, now with a tight contour around the target on the left ventricular wall and a proton beam entering through the chest and stopping at the target. — **With CardioKit.** The beam fires when the target reaches the planned position. Less margin. Less healthy tissue exposed.

02 / Two solutions

Target or Protect

TARGET

Dual gating

Deliver an ablative dose inside the heart: arrhythmia circuit, tumor, thickened septum.

CardioKit monitors the cardio-respiratory motion in real-time and gates the beam based on configured gating windows.

Cardiac radioablation →

PROTECT

Heart monitoring

A tumor in the lung, esophagus, mediastinum or breast, next to a heart that must be spared.

CardioKit monitors the cardio-respiratory motion and informs the clinical if it drifts towards the field.

Cardiac sparing →

03 / The system

See the heart Gate the beam

See

Live ultrasound of the heart itself. Zero imaging dose.

Track

Deep learning follows the target with high precision.

Gate

Heartbeat and breath, gated together.

Guard

Tracking confidence drops, the beam holds.

How it works →

04 / The market

Radiotherapy rooms manage motion but none see the heart directly

$2.6 BMotion management market by 2032^*

$235 MSurface guidance today, +10 % a year^*

12,000+Treatment rooms in service^*

4.8 MNew lung and breast cancers a year^*

Treatment rooms already pay for motion management. CardioKit improves motion management by watching the heart instead of surrogates. CardioKit addresses heart, lung and breast indications in radioablation, either by targeting or protecting the heart.

Dataintelo, TechSci Research, IAEA DIRAC, PTCOG (May 2025), GLOBOCAN 2022. Single-source analyst estimates, not EBAMed forecasts. Procedure counts are EBAMed estimates.

05 / Invest

Make the moving heart treatable in every radiotherapy room

€16 MSeries A 2023 Led by Panakès Partners

€2.4 MEIC Accelerator
non-dilutive

3+US patents granted United States Patent and Trademark Office

ISO 13485Certified QMS Certified by TÜV SÜD

Talk to us Clinical evidence

CardioKit is an investigational device: not CE-marked, not FDA-cleared, not for sale. First-in-human trials at clinical partner centers are the next milestone, funded by the 2023 Series A.

06 / Supported by